{{Rsnum
|rsid=868213
|Gene=EXOC3L
|Chromosome=16
|position=67186554
|Orientation=minus
|GMAF=0.1492
|Gene_s=EXOC3L1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 13.3 | 86.7
| HCB | 0.0 | 6.6 | 93.4
| JPT | 0.0 | 3.5 | 96.5
| YRI | 27.9 | 51.7 | 20.4
| ASW | 15.8 | 33.3 | 50.9
| CHB | 0.0 | 6.6 | 93.4
| CHD | 0.0 | 2.8 | 97.2
| GIH | 5.9 | 25.7 | 68.3
| LWK | 26.4 | 51.8 | 21.8
| MEX | 0.0 | 14.0 | 86.0
| MKK | 15.4 | 48.1 | 36.5
| TSI | 1.0 | 7.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=19854717
|Title=The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD)
|OA=1
}}

23andMe reports that each G allele at [[rs868213]] appears to be associated with 1.5x higher odds of [[ankylosing spondylitis]]. {{PMID|19854717|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}